Insights

Innovative Diagnostic Technology PhageTech's cutting-edge platform offers highly sensitive, rapid, and cost-effective disease marker detection, presenting an opportunity to partner with healthcare providers and diagnostic labs seeking advanced testing solutions.

Expanding Health Applications With demonstrated capabilities in detecting markers like PSMA and HSA, PhageTech’s technology can be integrated into diagnostic workflows for prostate cancer and kidney disease, opening avenues for collaborations in specialized medical markets.

Global Healthcare Impact The company's potential to revolutionize diagnostics worldwide creates opportunities to engage with international health organizations and medical device distributors focused on scalable, affordable testing solutions.

Early-stage Growth Potential Having secured $2.4 million in initial funding and operating with a small team, PhageTech is positioned for strategic partnerships to accelerate product development, clinical validation, and market entry.

Technology and Patent Portfolio With a robust patent-pending platform developed at UC Irvine, PhageTech offers a unique value proposition for technology licensing, co-development deals, and strategic alliances in the diagnostics space.

Similar companies to PhageTech, Inc.

PhageTech, Inc. Tech Stack

PhageTech, Inc. uses 8 technology products and services including Wix, Cloudflare, Webpack, and more. Explore PhageTech, Inc.'s tech stack below.

  • Wix
    Content Management System
  • Cloudflare
    Content Management System
  • Webpack
    Development
  • Module Federation
    Development
  • TweenMax
    Javascript Frameworks
  • RequireJS
    Javascript Frameworks
  • Zepto
    Javascript Libraries
  • Lodash
    Javascript Libraries

PhageTech, Inc.'s Email Address Formats

PhageTech, Inc. uses at least 1 format(s):
PhageTech, Inc. Email FormatsExamplePercentage
FLast@phagetech.comJDoe@phagetech.com
40%
First.Last@phagetech.comJohn.Doe@phagetech.com
10%
First@phagetech.comJohn@phagetech.com
10%
FLast@phagetech.comJDoe@phagetech.com
40%

Frequently Asked Questions

Where is PhageTech, Inc.'s headquarters located?

Minus sign iconPlus sign icon
PhageTech, Inc.'s main headquarters is located at 5 Mason Suite #170 Irvine, California 92618 United States. The company has employees across 1 continents, including North America.

What is PhageTech, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
PhageTech, Inc.'s official website is phagetech.com and has social profiles on LinkedIn.

What is PhageTech, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
PhageTech, Inc.'s SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does PhageTech, Inc. have currently?

Minus sign iconPlus sign icon
As of March 2026, PhageTech, Inc. has approximately 4 employees across 1 continents, including North America. Key team members include Co-Founder, Advisor: R. W. H.. Explore PhageTech, Inc.'s employee directory with LeadIQ.

What industry does PhageTech, Inc. belong to?

Minus sign iconPlus sign icon
PhageTech, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does PhageTech, Inc. use?

Minus sign iconPlus sign icon
PhageTech, Inc.'s tech stack includes WixCloudflareWebpackModule FederationTweenMaxRequireJSZeptoLodash.

What is PhageTech, Inc.'s email format?

Minus sign iconPlus sign icon
PhageTech, Inc.'s email format typically follows the pattern of FLast@phagetech.com. Find more PhageTech, Inc. email formats with LeadIQ.

How much funding has PhageTech, Inc. raised to date?

Minus sign iconPlus sign icon
As of March 2026, PhageTech, Inc. has raised $2.4M in funding. The last funding round occurred on Sep 28, 2015 for $2.4M.

When was PhageTech, Inc. founded?

Minus sign iconPlus sign icon
PhageTech, Inc. was founded in 2014.

PhageTech, Inc.

Medical Equipment ManufacturingCalifornia, United States2-10 Employees

PhageTech, Inc. is a California-based, developmental stage company applying an innovative approach for detecting disease markers in body fluids including urine and blood. Compared to current antibody-based assays, PhageTech's approach could offer improved sensitivity and performance. Furthermore, our technology has the potential to be more stable and less expensive than current testing methods.

The PhageTech, Inc. technology platform promises to deliver rapid and accurate diagnostic screening for testing at a fraction of current costs. The core technology utilized in PhageTech devices was developed by two research groups at the University of California, Irvine, and was the subject of nine pending and issued patents. Recently, protein sensing with the PhageTech platform has been demonstrated with PSMA (Prostate-specific membrane antigen) and HSA (Human Serum Albumin). These targets could impact the diagnosis of prostate cancer and kidney disease, respectively. Our technology has the potential to touch every field of medicine and profoundly impact the administration of health care around the world.

Section iconCompany Overview

Headquarters
5 Mason Suite #170 Irvine, California 92618 United States
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2014
Employees
2-10

Section iconFunding & Financials

  • $2.4M

    PhageTech, Inc. has raised a total of $2.4M of funding over 1 rounds. Their latest funding round was raised on Sep 28, 2015 in the amount of $2.4Mas a Series A.

  • $1M

    PhageTech, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $2.4M

    PhageTech, Inc. has raised a total of $2.4M of funding over 1 rounds. Their latest funding round was raised on Sep 28, 2015 in the amount of $2.4Mas a Series A.

  • $1M

    PhageTech, Inc.'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.